AIM: To investigate hypoxia inducible factor-1α's (HIF-1α) immunohistochemical expression in clear cell renal cell carcinoma (ccRCC) treated with radical nephrectomy. PATIENTS AND METHODS: One hundred and forty-eight patients were considered from those who underwent radical nephrectomy between 1983 ...
Clear-cell renal-cell carcinoma (ccRCC) is the most common pathological subtype of renal cell carcinoma (RCC), accounting for about 80% of RCC. In order to find potential prognostic biomarkers in ccRCC, we presented a four-gene signature to evaluate the prognosis of ccRCC. SurvExpress and immu...
Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening. BMC Genomics. 2017;18(Suppl 6): doi:10.1186/s12864-017-4026-6.Han,G., Zhao,W., Song,X., Ng,P.K.S., Karama,J.A., Jonasch,E., Mills,G.B., Zhao,Z., Ding...
Development of an Interferon Gamma Response-Related Signature for Prediction of Survival in Clear Cell Renal Cell Carcinoma_2021 格式:PDF 页数:17 上传日期:2025-02-19 10:26:51 浏览次数:1 下载积分:1000 加入阅读清单 0% 还剩16 页未读,是否继续阅读? 此文档由 jybib86 分享于 2025-02-19 ...
Clear cell renal carcinoma (ccRCC) is one of the most common cancers worldwide. In this study, a new model of immune-related genes was developed to predict the overall survival and immunotherapy efficacy in patients with ccRCC. Immune-related genes were obtained from the ImmPort database. Clini...
Genetic changes underlying clear cell renal cell carcinoma (ccRCC) include alterations in genes controlling cellular oxygen sensing (for example, VHL) and the maintenance of chromatin states (for example, PBRM1). We surveyed more than 400 tumours using d
Twenty-year survival after iterative surgery for metastatic renal cell carcinoma: a case report and review of literature[J]. World J Clin Cases, 2020,8(19):4450-4465. [15] 朱焱,韩翠红,杨叶琳,等.转移性肾细胞癌196例临床病理学特征[J].中华病理学杂志,2020,49(12):1255-1260. [16] Sheng ...
Clear cell renal cell carcinoma (ccRCC) is the most common subtype of kidney cancer whose incidence and mortality rate are increasing. Identifying immune-related lncRNAs and constructing a model would probably provide new insights into biomarkers and immunotherapy for ccRCC and aid in the prognosis ...
Identifying tumor-cell-specific markers and elucidating their epigenetic regulation and spatial heterogeneity provides mechanistic insights into cancer etiology. Here, we perform snRNA-seq and snATAC-seq in 34 and 28 human clear cell renal cell carcinoma (ccRCC) specimens, respectively, with matched bul...
Shinmei S, Sakamoto N, Goto K, et al: MicroRNA-155 is a predictive marker for survival in patients with clear cell renal cell carcinoma. Int J Urol 20: 468-477, 2013.Shinmei S, Sakamoto N, Goto K et al. MicroRNA-155 is a predictive mar- ker for survival in patients with clear...